ROTHSCHILD INVESTMENT LLC /IL - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 183 filers reported holding CARA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROTHSCHILD INVESTMENT LLC /IL ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$18
-58.1%
10,600
-29.8%
0.00%
-50.0%
Q2 2023$43
-69.1%
15,100
-46.8%
0.00%
-66.7%
Q1 2023$139
-78.1%
28,400
-51.9%
0.01%
-79.3%
Q4 2022$634
-99.9%
59,000
+1.9%
0.06%
+7.4%
Q3 2022$542,000
+15.6%
57,900
+12.6%
0.05%
+25.6%
Q2 2022$469,000
-25.0%
51,4000.0%0.04%
-12.2%
Q1 2022$625,000
+4.9%
51,400
+5.1%
0.05%
+6.5%
Q4 2021$596,000
-21.2%
48,9000.0%0.05%
-27.0%
Q3 2021$756,000
+41.6%
48,900
+30.7%
0.06%
+50.0%
Q2 2021$534,000
-37.0%
37,400
-4.1%
0.04%
-42.5%
Q1 2021$847,000
+53.7%
39,000
+7.1%
0.07%
+37.7%
Q4 2020$551,000
+32.1%
36,400
+11.0%
0.05%
+17.8%
Q3 2020$417,000
-20.9%
32,800
+6.5%
0.04%
-28.6%
Q2 2020$527,000
+52.3%
30,800
+17.6%
0.06%
+40.0%
Q1 2020$346,000
-19.3%
26,200
-1.5%
0.04%
+4.7%
Q4 2019$429,000
-11.7%
26,6000.0%0.04%
-24.6%
Q3 2019$486,000
-24.2%
26,600
-10.7%
0.06%
-25.0%
Q2 2019$641,000
+53.3%
29,800
+39.9%
0.08%
+55.1%
Q1 2019$418,000
+47.7%
21,300
-2.3%
0.05%
+28.9%
Q4 2018$283,000
-48.4%
21,800
-4.8%
0.04%
-41.5%
Q3 2018$548,000
+26.6%
22,900
+1.3%
0.06%
+18.2%
Q2 2018$433,000
+56.9%
22,600
+1.3%
0.06%
+57.1%
Q1 2018$276,000
+57.7%
22,300
+55.9%
0.04%
+84.2%
Q4 2017$175,00014,3000.02%
Other shareholders
CARA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Ridgeback Capital Investments L.P. 622,140$10,489,00045.13%
RHO CAPITAL PARTNERS INC 2,668,057$44,983,00015.47%
Opaleye Management Inc. 427,000$7,199,0003.01%
DAFNA Capital Management LLC 169,331$2,855,0002.54%
Private Capital Advisors, Inc. 246,850$4,162,0001.80%
WALL STREET ASSOCIATES 192,300$3,242,0000.91%
SECTORAL ASSET MANAGEMENT INC 1,212,578$20,444,0000.87%
Virtus ETF Advisers LLC 17,299$292,0000.80%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 618,140$10,422,0000.58%
SPHERA FUNDS MANAGEMENT LTD. 197,820$3,335,0000.49%
View complete list of CARA THERAPEUTICS INC shareholders